Harvard Bioscience Stock Price. Everything You Need To Know About The Harvard Bioscience Stock!
Harvard Bioscience, Inc. is a company based in Holliston, Massachusetts that develops, manufactures, and sells technologies, products, and services used in fundamental research, discovery, and pre-clinical testing for drug development. The company went public on October 21, 2013, and currently employs 436 full-time employees.
Harvard Bioscience, Inc. has organized its product line activities into two product families, cellular and molecular technology (CMT) and preclinical. The CMT product family consists of products supporting research related to molecular, cellular, organ, and organoid technologies, with additional applications in the field of bio-production of pharmaceuticals and therapeutics.
The preclinical product family includes four business lines that support the preclinical research and testing phase for drug development, specifically testing related to data collection and analysis for safety and regulatory compliance. The company’s brands include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and others.
Investors interested in the stock price today of companies that provide technologies and products used in drug development should keep an eye on Harvard Bioscience, Inc. The company’s broad range of products and services may present an attractive investment opportunity for those looking to diversify their portfolio. However, it is essential to research and stay informed about companies like Harvard Bioscience, Inc. to make informed investment decisions and potentially benefit from stock price increases in the future.
Harvard Bioscience Stock Price. Everything You Need To Know About The Harvard Bioscience Stock! performance
- Employees 436
- Company HQ Holliston
- Website https://www.harvardbioscience.com/
- HBIO Asset Type Common Stock
- HBIO Market Capitalization 165.9M
- Earnings Per Share -0.08
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth -0.803
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking for investment opportunities in the United States? Look no further than Harvard Bioscience, a promising stock that offers immense potential for growth. As an innovative life sciences company, Harvard Bioscience focuses on developing and manufacturing novel technologies to advance scientific research. By investing in Harvard Bioscience, you have the chance to be part of groundbreaking discoveries and contribute to life-changing advancements. At Zorion, we provide investment insights and recommendations specifically tailored for retail investors from Malaysia, Thailand, Indonesia, and Vietnam. Our platform offers the necessary resources and educational materials to help you make informed decisions about investing in Harvard Bioscience. Start your journey towards successful investing today!
